Genpharmasec Ltd (BSE: 531592) is a Mumbai, Maharashtra-based company in the Chemical Distribution industry. With a market capitalisation of ₹61 Cr, it ranks #3,638 by market cap among the 6,197 Indian listed companies on FinBizNet, and #34 of 84 in Chemical Distribution. At ₹1.08 (as of 16 Nov 2026), the share price is 33.3% below its 52-week high of ₹1.62 and 42.1% above its 52-week low of ₹0.76. The share price is down 28.9% over one year and up 5.9% over three months.
| Current Price | ₹1.08 |
|---|---|
| Market Cap | ₹61 Cr |
| BSE Code | 531592 |
| Sector | Industrials > Capital Goods > Trading Companies and Distributors |
| Sub-Industry | Trading Companies and Distributors > Chemical Distribution |
| P/E Ratio | 37.6 |
| Return on Equity | 0.86% |
| Return on Assets | -0.46% |
| 52-Week Range | ₹0.76 – ₹1.62 |
| 1-Year Price Change | -28.9% |
| 3-Month Price Change | +5.9% |
| Beta (1Y) | 0.59 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.genpharmasec.com |
| Revenue | ₹45 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 3.5% |
| EPS (Basic) | ₹0.03 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Genpharmasec Ltd reported revenue of ₹45 Cr in Q1 FY27, up 269.8% from ₹12 Cr in Q1 FY26 and down 13.3% from ₹52 Cr in Q4 FY26. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹2 Cr in Q1 FY26 (up 0.6%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹12 Cr (Q1 FY26) to ₹52 Cr (Q4 FY26). The company reported a net loss in 1 of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹45 Cr | ₹2 Cr | 3.5% |
| Q4 FY26 | ₹52 Cr | ₹2 Cr | 4.5% |
| Q3 FY26 | ₹36 Cr | ₹1 Cr | 2.1% |
| Q2 FY26 | ₹32 Cr | ₹1 Cr | 2.6% |
| Q1 FY26 | ₹12 Cr | ₹2 Cr | 12.9% |
| Q4 FY25 | ₹14 Cr | −₹0 Cr | −1.7% |
Standalone figures (₹ crore, XBRL filings).
Delivery averaged 83.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Genpharmasec Limited buys, sells, and distributes pharmaceutical activities and services in India. The company operates through two segments, Diagnostic Pharma Equipment, and Investment and Trading in Securities. The Diagnostic Pharma Equipment segment distributes state-of-the-art diagnostic equipment comprising of i-STAT analyzers and its cartridges used to analyze blood for test results in Intensive Care Units (ICUs) of hospitals. The Investment and Trading in Securities segment operates in secondary securities market. The company was formerly known as Generic Pharmasec Limited and changed its name to Genpharmasec Limited in October 2021. Genpharmasec Limited was incorporated in 1992 and is based in Mumbai, India.
1. Pharmaceuticals-This segment engages in the dealing of pharmaceutical products. 2. Trading in Securities-This segment trades in securities. 3. Un-Allocated-0 4. Segment Adjustment-0
1. Pharmaceuticals-93.5% 2. Manufacturing & Processing-5.8% 3. Laboratory Testing-0.7%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Mmtc Ltd. | ₹8,048 Cr | 20.8 | 20.27% | ₹1 Cr | -14.5% |
| Refex Industries Limited | ₹3,232 Cr | 13.1 | 17.82% | ₹761 Cr | -34.7% |
| Fischer Chemic Ltd. | ₹1,654 Cr | 54.3 | 8.63% | ₹107 Cr | -73.6% |
| The Yamuna Syndicate Ltd | ₹799 Cr | 15.4 | 4.03% | — | -27.8% |
| Shiv Aum Steels Limited | ₹750 Cr | 100.9 | 6.08% | ₹166 Cr | +84.2% |
| Uniphos Enterprises Ltd. | ₹672 Cr | 31.7 | 0.80% | ₹0 Cr | -37.9% |
| State Trading Corporation Of India Ltd. | ₹654 Cr | 26.4 | -0.54% | ₹0 Cr | -10.8% |
| MEGAMONT LIMITED | ₹604 Cr | 92.6 | — | — | +231.1% |
| Genpharmasec Ltd | ₹61 Cr | 37.6 | 0.86% | ₹45 Cr | -28.9% |
Listed by market capitalisation. Ratios are shown for context only.
Genpharmasec Ltd is trading at ₹1.08, with a market capitalisation of ₹61 Cr.
Genpharmasec Ltd operates in the Industrials > Capital Goods > Trading Companies and Distributors space (Trading Companies and Distributors > Chemical Distribution).
Genpharmasec Ltd has a P/E of 37.6 and a return on equity of 0.86%.
Genpharmasec Ltd is listed on the BSE under the scrip code 531592.
Genpharmasec Ltd's share price is down 28.9% over one year and up 5.9% over three months. Its 52-week range is ₹0.76 to ₹1.62.
In Q1 FY27, Genpharmasec Ltd reported revenue of ₹45 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.03 (standalone, parsed from the company's exchange filing).
Genpharmasec Ltd reported revenue of ₹45 Cr in Q1 FY27, up 269.8% from ₹12 Cr in Q1 FY26 and down 13.3% from ₹52 Cr in Q4 FY26.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.